Browsing Category
DCAT Member Company Community
133 posts
ICYMI: Production to Prescription Podcast: Drug Launches & Approvals in 2025: The Blockbuster Contenders
By
Each year, the promise of new market entries loom in the bio/pharmaceutical industry. Which products, launched or approved thus far in 2025, may be potential blockbusters (defined as drugs with sales of $1…
ICYMI: DCAT Production to Prescription Podcast: “Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025?”
By
Biotech companies are an important source for innovation and product development for larger companies and are an important customer base of CDMOs/CMOs. Capital flow in the biotech sector, a key…
DCAT Awards Grants To Student Scientists at the 2025 Regeneron International Science & Engineering Fair
By
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of four projects who participated in the Regeneron International Science & Engineering Fair (Regeneron…
New Podcast Episode! Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
By
What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies)? Is there too much capacity or is the market tight? The latest episode of…
